DOSSIER · 13F-HR · Q2 2026

NEXTBio Capital Management LP

$217M in tracked AUM across 22 positions as of Q2 2026.

NC
CIK 0002038158 · last filed Jun 30, 2026
Total AUM
$217M
as of Q2 2026
Holdings
22
positions
Whale Score
62
62
tracked
Activity
no data
changes this Q
AI Analysis · Q2 2026

NEXTBio Capital Management LP filed its latest 13F-HR for Q2 2026. See the latest holdings and position changes below.

Quarter at a glance — Q2 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q2 2026.

#HoldingValueSharesWeight
01
PTGX
PROTAGONIST THERAPEUTICS INC
$27M219K12.4%
02
STTK
SHATTUCK LABS INC
$26M3.7M11.9%
03
CMPS
COMPASS PATHWAYS PLC
$25M1.8M11.6%
04
GPCR
STRUCTURE THERAPEUTICS INC
$17M312K7.7%
05
VOR
VOR BIOPHARMA INC
$16M889K7.5%
06
RYTM
RHYTHM PHARMACEUTICALS INC
$15M132K6.7%
07
PVLA
PALVELLA THERAPEUTICS INC NE
$14M90K6.3%
08
XENE
XENON PHARMACEUTICALS INC
$11M183K5.1%
09
ZBIO
ZENAS BIOPHARMA INC
$11M427K5.0%
10
ORIC
ORIC PHARMACEUTICALS INC
$8M706K3.5%

Filing history

2026Q2Jun 30
$217M 0.9%
22 positionsView →
2026Q1Mar 31
$215M 26.3%
24 positionsView →
2025Q4Dec 31
$170M
23 positionsView →